Advances in use of the 5-HT3 receptor antagonists (Q33181781)

23 July 2017

1 reference

title

Advances in use of the 5-HT3 receptor antagonists (English)

1 reference

23 July 2017

Walton SM

1

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Expert Opinion on Pharmacotherapy

23 July 2017

published in

1 reference

23 July 2017

volume

1

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

207-223

1 reference

Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

The control of chemotherapy-induced emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Comparison of two different doses of ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced emesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Proposal for classifying the acute emetogenicity of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

Ondansetron and Tropisetron with Dexamethasone in the Prophylaxis of Acute Vomiting Induced by Non-cisplatin-Containing Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.2.207

21 January 2018

Identifiers

DOI

10.1517/14656566.1.2.207

1 reference

23 July 2017

1 reference